A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students
Christine C. Lee(Rensselaer Polytechnic Institute), Hannah L. Kirking(Centers for Disease Control and Prevention), Dustin W. Currie(Centers for Disease Control and Prevention), Clint N. Morgan(Centers for Disease Control and Prevention), Hannah G. Rosenblum(National Center for Immunization and Respiratory Diseases), Patrick Remington(University of Wisconsin Health), Allen Bateman, Monique A. Foster(Centers for Disease Control and Prevention), Glen R. Abedi(Centers for Disease Control and Prevention), Ryan P. Westergaard(University of Wisconsin–Madison), Alana Sterkel, Hannah E. Segaloff(Wisconsin Department of Health Services), Juliana Kahrs(University of Wisconsin–Oshkosh), Jacqueline E. Tate(National Center for Immunization and Respiratory Diseases), Tarah Somers(Centers for Disease Control and Prevention), Patrick Kelly(University of Wisconsin–Madison), John Paul Bigouette(Centers for Disease Control and Prevention), Christopher H. Hsu(Centers for Disease Control and Prevention), Kimberly Langolf(University of Wisconsin–Oshkosh), Thomas J. Whyte, David Payne(Centers for Disease Control and Prevention), Devlin Cole(Wisconsin Department of Health Services), Jeanne C. Ruff(Centers for Disease Control and Prevention), Rodel Desamu-Thorpe(Centers for Disease Control and Prevention)
Cited by 6
Related Papers
Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021
|Preventing Chronic Disease|2021|370
Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana
|The Journal of Infectious Diseases|2016|310
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
|MMWR Morbidity and Mortality Weekly Report|2021|215